Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease

Herd, Clare P, Tomlinson, Claire L, Deane, Katherine, Brady, Marian C, Smith, Christina H, Sackley, Catherine M and Clarke, Carl E (2012) Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease. Cochrane database of systematic reviews (Online), 8. CD002812.

[img]
Preview
PDF (Herd-2012-Speech and language) - Published Version
Download (401kB) | Preview

    Abstract

    Parkinson's disease patients commonly suffer from speech and vocal problems including dysarthric speech, reduced loudness and loss of articulation. These symptoms increase in frequency and intensity with progression of the disease). Speech and language therapy (SLT) aims to improve the intelligibility of speech with behavioural treatment techniques or instrumental aids.

    Item Type: Article
    Uncontrolled Keywords: randomized controlled trials as topic,watchful waiting,parkinson disease,speech intelligibility,humans,dysarthria,speech therapy,language therapy
    Faculty \ School: ?? NSC ??
    Faculty of Medicine and Health Sciences > School of Rehabilitation Sciences
    Depositing User: Pure Connector
    Date Deposited: 16 Oct 2013 01:43
    Last Modified: 24 May 2019 15:30
    URI: https://ueaeprints.uea.ac.uk/id/eprint/43707
    DOI: 10.1002/14651858.CD002812.pub2

    Actions (login required)

    View Item